TECLENS
TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, and more.
TECLENS
Industry:
Health Care Medical Device
Founded:
2013-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.teclens.com
Total Employee:
1+
Status:
Active
Total Funding:
5.64 M USD
Technology used in webpage:
CloudFront Sucuri Hosting
Similar Organizations
Avisi Technologies
Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.
InnaMed
Launching HomeLab, a gateway to personalized healthcare in the comfort and privacy of your home. Measure + Analyze + Enhance.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
MATTER
MATTER provides the healthcare industry with technology solutions to improve products and services.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
Pulse Biosciences
Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Current Employees Featured
Founder
Official Site Inspections
http://www.teclens.com Semrush global rank: 2.5 M Semrush visits lastest month: 7.39 K
- Host name: 28.109.212.35.bc.googleusercontent.com
- IP address: 35.212.109.28
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "TECLens"
TECLens – The Future of Vision Correction
The procedure aims to be a comfortable, non-invasive, in-office treatments. While initially focused on presbyopia, TECLens is exploring future applications for hyperopia, progressive myopia in …See details»
About – TECLens
At TECLens, we are dedicated to transforming the future of vision care by pioneering non-invasive, personalized corneal cross-linking treatments. Our breakthrough qCXL™ technology …See details»
TECLens - Crunchbase Company Profile & Funding
TECLens raised $9.3 million in a Series A funding round to support the clinical development of its non-incisional refractive correction procedure. The funding was co-led by Johnson & Johnson …See details»
TECLens - LinkedIn
TECLens is a clinical-stage ophthalmic medical device company, pioneering non-invasive personalized corneal cross-linking technology (qCXL™) for vision correction. Our innovative CXLens® system ...See details»
Management Team – TECLens
TECLens, Inc. 9 Riverbend Dr. South Stamford, CT 06907Copyright © 2024 TECLens, Inc. All rights reserved.See details»
TECLens 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for TECLens. Use the PitchBook Platform to explore the full profile.See details»
Johnson & Johnson Invests in Refractive Technology …
Finding opportunities to bring cutting-edge innovation to address the world’s most pressing eye health issues is a key driver behind how Johnson & Johnson operates.See details»
TECLens - Funding, Financials, Valuation & Investors
TECLens develops technology to treat keratoconus and correct vision problems.See details»
TECLens - Products, Competitors, Financials, Employees, …
About TECLens TECLens focuses on the development of vision correction technologies within the healthcare sector. It offers a non-invasive, incision-less technology known as quantitative …See details»
TECLens - Org Chart, Teams, Culture & Jobs | The Org
View TECLens' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Johnson & Johnson Invests in Start-Up TECLens | OBN
Jul 25, 2024 Johnson & Johnson has invested in TECLens, a start-up advancing non-incisional refractive correction technology via corneal cross-linking.See details»
TECLens - Contacts, Employees, Board Members, Advisors & Alumni
TECLens develops technology to treat keratoconus and correct vision problems.See details»
Johnson & Johnson announces investment in TECLens for …
Johnson & Johnson Innovation has invested in Series A funding for the start-up TECLens, which is developing a novel, nonincisional refractive correction procedure that uses a corneal cross …See details»
TECLens Raises $9.3M for Refractive Technology | OBN
Feb 12, 2025 TECLens secures $9.3M in Series A funding to advance its noninvasive refractive correction technology using corneal cross-linking.See details»
Contact Us – TECLens
We’d love to hear from you! Whether you have questions about our technology, need support, or want to discuss potential partnerships, our team is here to assist you. Please use the contact …See details»
TEClens | Ophthalmology Innovation Source
TECLens’ initial product, CXLens, is a one-time use, disposable contact lens that is connected to a small, portable, low cost control system. CXLens sits comfortably directly on the eye, …See details»
TECLens Secures $9.3 Million Series A Funding to Advance Its Non ...
Feb 12, 2025 STAMFORD, Conn.-- (BUSINESS WIRE)-- TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today it raised $9.3 million in a Series A …See details»
Our Mission – TECLens
TECLens was founded with a social conscience. Unlike other CXL systems, our solution is low cost, highly portable and very simple to use, and in fact, does not even require a clinical …See details»
TECLens Secures $9.3 Million Series A Funding to Advance Its Non ...
Feb 11, 2025 News TECLens Secures $9.3 Million Series A Funding to Advance Its Non-invasive Refractive Technology The funding is allocated to support the clinical development of …See details»
Technology – TECLens
Quantitative Cross-Linking (qCXL™) is proprietary technology designed to gently reshape the cornea. Developed to address the growing presbyopic population, the system aims to be a …See details»